168 related articles for article (PubMed ID: 21449672)
1. Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy.
Kwan P; Wong V; Ng PW; Lui CH; Sin NC; Wong KS; Baum L
Pharmacogenomics; 2011 Mar; 12(3):319-25. PubMed ID: 21449672
[TBL] [Abstract][Full Text] [Related]
2. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.
Qu J; Zhou BT; Yin JY; Xu XJ; Zhao YC; Lei GH; Tang Q; Zhou HH; Liu ZQ
CNS Neurosci Ther; 2012 Aug; 18(8):647-51. PubMed ID: 22630058
[TBL] [Abstract][Full Text] [Related]
3. Gene-wide tagging study of association between ABCB1 polymorphisms and multidrug resistance in epilepsy in Han Chinese.
Kwan P; Wong V; Ng PW; Lui CH; Sin NC; Poon WS; Ng HK; Wong KS; Baum L
Pharmacogenomics; 2009 May; 10(5):723-32. PubMed ID: 19450124
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients.
Ogasawara K; Chitnis SD; Gohh RY; Christians U; Akhlaghi F
Clin Pharmacokinet; 2013 Sep; 52(9):751-62. PubMed ID: 23633119
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk.
Campa D; Butterbach K; Slager SL; Skibola CF; de Sanjosé S; Benavente Y; Becker N; Foretova L; Maynadie M; Cocco P; Staines A; Kaaks R; Boffetta P; Brennan P; Conde L; Bracci PM; Caporaso NE; Strom SS; Camp NJ; Cerhan JR; ; Canzian F; Nieters A
Int J Cancer; 2012 Aug; 131(4):803-12. PubMed ID: 21918980
[TBL] [Abstract][Full Text] [Related]
6. Specific OCT1 and ABCG2 polymorphisms are associated with Lamotrigine concentrations in Chinese patients with epilepsy.
Shen CH; Zhang YX; Lu RY; Jin B; Wang S; Liu ZR; Tang YL; Ding MP
Epilepsy Res; 2016 Nov; 127():186-190. PubMed ID: 27610747
[TBL] [Abstract][Full Text] [Related]
7. Exon sequencing and high resolution haplotype analysis of ABC transporter genes implicated in drug resistance.
Leschziner G; Zabaneh D; Pirmohamed M; Owen A; Rogers J; Coffey AJ; Balding DJ; Bentley DB; Johnson MR
Pharmacogenet Genomics; 2006 Jun; 16(6):439-50. PubMed ID: 16708052
[TBL] [Abstract][Full Text] [Related]
8. Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo.
Colombo S; Soranzo N; Rotger M; Sprenger R; Bleiber G; Furrer H; Buclin T; Goldstein D; Décosterd L; Telenti A;
Pharmacogenet Genomics; 2005 Sep; 15(9):599-608. PubMed ID: 16041239
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy.
Kim DW; Lee SK; Chu K; Jang IJ; Yu KS; Cho JY; Kim SJ
Epilepsy Res; 2009 Mar; 84(1):86-90. PubMed ID: 19167193
[TBL] [Abstract][Full Text] [Related]
10. Association between the polymorphisms in the ATP-binding cassette genes ABCB1 and ABCC2 and the risk of drug-resistant epilepsy in a Chinese Han population.
Xue T; Lu ZN
Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27886333
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan pharmacokinetics in Japanese renal transplant recipients.
Miura M; Satoh S; Inoue K; Saito M; Habuchi T; Suzuki T
Clin Chim Acta; 2009 Jan; 399(1-2):83-7. PubMed ID: 18838068
[TBL] [Abstract][Full Text] [Related]
12. Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.
Tian C; Ambrosone CB; Darcy KM; Krivak TC; Armstrong DK; Bookman MA; Davis W; Zhao H; Moysich K; Gallion H; DeLoia JA
Gynecol Oncol; 2012 Mar; 124(3):575-81. PubMed ID: 22112610
[TBL] [Abstract][Full Text] [Related]
13. The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients.
Chew SC; Singh O; Chen X; Ramasamy RD; Kulkarni T; Lee EJ; Tan EH; Lim WT; Chowbay B
Cancer Chemother Pharmacol; 2011 Jun; 67(6):1471-8. PubMed ID: 21468756
[TBL] [Abstract][Full Text] [Related]
14. Impact of ABCC2, ABCG2 and SLCO1B1 polymorphisms on the pharmacokinetics of pitavastatin in humans.
Oh ES; Kim CO; Cho SK; Park MS; Chung JY
Drug Metab Pharmacokinet; 2013; 28(3):196-202. PubMed ID: 23007012
[TBL] [Abstract][Full Text] [Related]
15. Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.
Soranzo N; Kelly L; Martinian L; Burley MW; Thom M; Sali A; Kroetz DL; Goldstein DB; Sisodiya SM
Epilepsia; 2007 Apr; 48(4):674-83. PubMed ID: 17437410
[TBL] [Abstract][Full Text] [Related]
16. Genetic association analysis of ATP binding cassette protein family reveals a novel association of ABCB1 genetic variants with epilepsy risk, but not with drug-resistance.
Balan S; Bharathan SP; Vellichiramal NN; Sathyan S; Joseph V; Radhakrishnan K; Banerjee M
PLoS One; 2014; 9(2):e89253. PubMed ID: 24586633
[TBL] [Abstract][Full Text] [Related]
17. ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population.
Zhou L; Cao Y; Long H; Long L; Xu L; Liu Z; Zhang Y; Xiao B
Pharmazie; 2015 Jun; 70(6):416-20. PubMed ID: 26189305
[TBL] [Abstract][Full Text] [Related]
18. Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.
Miura M; Kagaya H; Satoh S; Inoue K; Saito M; Habuchi T; Suzuki T
Ther Drug Monit; 2008 Oct; 30(5):559-64. PubMed ID: 18695635
[TBL] [Abstract][Full Text] [Related]
19. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy.
Ufer M; Mosyagin I; Muhle H; Jacobsen T; Haenisch S; Häsler R; Faltraco F; Remmler C; von Spiczak S; Kroemer HK; Runge U; Boor R; Stephani U; Cascorbi I
Pharmacogenet Genomics; 2009 May; 19(5):353-62. PubMed ID: 19415824
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of ABCG2, ABCB1 and HNF4α are associated with Lamotrigine trough concentrations in epilepsy patients.
Zhou Y; Wang X; Li H; Zhang J; Chen Z; Xie W; Zhang J; Li J; Zhou L; Huang M
Drug Metab Pharmacokinet; 2015 Aug; 30(4):282-7. PubMed ID: 26213157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
